High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer

Scavenger receptor class B type I (SR-BI) has been linked to the development and progression of breast cancer. However, its clinical significance in breast cancer remains unclear. Here, we evaluated SR-BI expression in a well-characterized breast cancer tissue microarray by immunohistochemistry. Hig...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Tumor biology Ročník 37; číslo 3; s. 3581 - 3588
Hlavní autori:	Yuan, Baoying, Wu, Changshun, Wang, Xingwen, Wang, Dan, Liu, Huiling, Guo, Ling, Li, Xiang-An, Han, Junqing, Feng, Hong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Dordrecht Springer Netherlands 01.03.2016 Springer Nature B.V
Predmet:	Adult Aged Biomarkers, Tumor - biosynthesis Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer Research Female Follow-Up Studies Humans Immunohistochemistry Kaplan-Meier Estimate Lymphatic Metastasis Medical prognosis Middle Aged Multivariate Analysis Neoplasm Staging Original Article Prognosis Proportional Hazards Models Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Scavenger Receptors, Class B - biosynthesis Tissue Array Analysis - methods Tissue Array Analysis - statistics & numerical data Tumor Burden Tumors Immunohistochemistry Scavenger receptor class B type I Breast cancer Prognosis
ISSN:	1010-4283, 1423-0380
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Scavenger receptor class B type I (SR-BI) has been linked to the development and progression of breast cancer. However, its clinical significance in breast cancer remains unclear. Here, we evaluated SR-BI expression in a well-characterized breast cancer tissue microarray by immunohistochemistry. High SR-BI expression was observed in 54 % of all breast cancer cases and was significantly associated with advanced pTNM stage ( P = 0.002), larger tumor size ( P = 0.023), lymph node metastasis ( P = 0.012), and the absence of ER ( P = 0.014). The Kaplan–Meier survival analysis revealed that patients with high SR-BI expression had significantly shorter overall survival (OS) ( P = 0.004). Moreover, multivariate analysis with adjustment for other prognostic factors confirmed that SR-BI was an independent prognostic factor for patient outcome ( P = 0.017). Overall, our study demonstrated that high SR-BI expression was related to conventional parameters indicative of more aggressive tumor type and may serve as a new prognostic marker for poor clinical outcome in human breast cancer.
AbstractList	Scavenger receptor class B type I (SR-BI) has been linked to the development and progression of breast cancer. However, its clinical significance in breast cancer remains unclear. Here, we evaluated SR-BI expression in a well-characterized breast cancer tissue microarray by immunohistochemistry. High SR-BI expression was observed in 54 % of all breast cancer cases and was significantly associated with advanced pTNM stage (P=0.002), larger tumor size (P=0.023), lymph node metastasis (P=0.012), and the absence of ER (P=0.014). The Kaplan-Meier survival analysis revealed that patients with high SR-BI expression had significantly shorter overall survival (OS) (P=0.004). Moreover, multivariate analysis with adjustment for other prognostic factors confirmed that SR-BI was an independent prognostic factor for patient outcome (P=0.017). Overall, our study demonstrated that high SR-BI expression was related to conventional parameters indicative of more aggressive tumor type and may serve as a new prognostic marker for poor clinical outcome in human breast cancer. Scavenger receptor class B type I (SR-BI) has been linked to the development and progression of breast cancer. However, its clinical significance in breast cancer remains unclear. Here, we evaluated SR-BI expression in a well-characterized breast cancer tissue microarray by immunohistochemistry. High SR-BI expression was observed in 54 % of all breast cancer cases and was significantly associated with advanced pTNM stage (P = 0.002), larger tumor size (P = 0.023), lymph node metastasis (P = 0.012), and the absence of ER (P = 0.014). The Kaplan-Meier survival analysis revealed that patients with high SR-BI expression had significantly shorter overall survival (OS) (P = 0.004). Moreover, multivariate analysis with adjustment for other prognostic factors confirmed that SR-BI was an independent prognostic factor for patient outcome (P = 0.017). Overall, our study demonstrated that high SR-BI expression was related to conventional parameters indicative of more aggressive tumor type and may serve as a new prognostic marker for poor clinical outcome in human breast cancer. Scavenger receptor class B type I (SR-BI) has been linked to the development and progression of breast cancer. However, its clinical significance in breast cancer remains unclear. Here, we evaluated SR-BI expression in a well-characterized breast cancer tissue microarray by immunohistochemistry. High SR-BI expression was observed in 54 % of all breast cancer cases and was significantly associated with advanced pTNM stage ( P = 0.002), larger tumor size ( P = 0.023), lymph node metastasis ( P = 0.012), and the absence of ER ( P = 0.014). The Kaplan–Meier survival analysis revealed that patients with high SR-BI expression had significantly shorter overall survival (OS) ( P = 0.004). Moreover, multivariate analysis with adjustment for other prognostic factors confirmed that SR-BI was an independent prognostic factor for patient outcome ( P = 0.017). Overall, our study demonstrated that high SR-BI expression was related to conventional parameters indicative of more aggressive tumor type and may serve as a new prognostic marker for poor clinical outcome in human breast cancer.
Author	Liu, Huiling Li, Xiang-An Wang, Dan Han, Junqing Wu, Changshun Feng, Hong Yuan, Baoying Wang, Xingwen Guo, Ling
Author_xml	– sequence: 1 givenname: Baoying surname: Yuan fullname: Yuan, Baoying organization: Cancer Center, Shandong Provincial Hospital affiliated to Shandong University, Shandong University – sequence: 2 givenname: Changshun surname: Wu fullname: Wu, Changshun organization: Department of Orthopedics, Shandong Provincial Hospital affiliated to Shandong University, Shandong University – sequence: 3 givenname: Xingwen surname: Wang fullname: Wang, Xingwen organization: Cancer Center, Shandong Provincial Hospital affiliated to Shandong University, Shandong University – sequence: 4 givenname: Dan surname: Wang fullname: Wang, Dan organization: Department of Pediatrics, Saha Cardiovascular Research Center, University of Kentucky College of Medicine – sequence: 5 givenname: Huiling surname: Liu fullname: Liu, Huiling organization: Cancer Center, Shandong Provincial Hospital affiliated to Shandong University, Shandong University – sequence: 6 givenname: Ling surname: Guo fullname: Guo, Ling organization: Department of Central Lab, Shandong Provincial Hospital affiliated to Shandong University – sequence: 7 givenname: Xiang-An surname: Li fullname: Li, Xiang-An email: 18753157528@163.com organization: Department of Pediatrics, Saha Cardiovascular Research Center, University of Kentucky College of Medicine – sequence: 8 givenname: Junqing surname: Han fullname: Han, Junqing email: junqinghan1@126.com organization: Cancer Center, Shandong Provincial Hospital affiliated to Shandong University, Shandong University – sequence: 9 givenname: Hong surname: Feng fullname: Feng, Hong email: hongfeng1268@126.com organization: Cancer Center, Shandong Provincial Hospital affiliated to Shandong University, Shandong University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26456958$$D View this record in MEDLINE/PubMed
BookMark	eNp9kc1u1TAQhS1URNsLD8AGWWLDJuC_GztLqAqtVIkNrC3bmYRUuXbwOKh9exxuQagSrMYaf2fmaM45OYkpAiEvOXvLGdPvkEuhdcP4vlFc8UY9IWdcCdkwadhJfTPOGiWMPCXniLesgl3XPiOnolX7ttubM3J3NY3fKAb3A-IImWYIsJSUaZgdIv1Ay_0C9JrC3ZIBcUqRTlip2RXoaUm0rIdKu3H89V2n1EJd7OmSan_JaYwJq2SK1GdwWGhwMUB-Tp4ObkZ48VB35OvHyy8XV83N50_XF-9vmiC1KI0xgzNt3znDoDNKa2l0653vgQnoWd_yTjK_D8bXvvGDB8UG4WQvIBiQXu7Im-PcauX7CljsYcIA8-wipBUt13Wq6oTUFX39CL1Na47V3UbJTqpt_468eqBWf4DeLnk6uHxvf9-0AvwIhJwQMwx_EM7slps95mZrHHbLzaqq0Y80YSqu1HOX7Kb5v0pxVGLdskX4l-l_in4CT2Gs3w
CitedBy_id	crossref_primary_10_1039_D3NR00196B crossref_primary_10_1016_j_ajpc_2025_101073 crossref_primary_10_7717_peerj_19915 crossref_primary_10_4155_tde_2017_0122 crossref_primary_10_3389_fonc_2017_00126 crossref_primary_10_3389_fphar_2016_00466 crossref_primary_10_2478_ii_2018_0011 crossref_primary_10_3390_ijms20051063 crossref_primary_10_3390_jcm8060853 crossref_primary_10_1097_MOL_0000000000000413 crossref_primary_10_1080_14737140_2019_1624529 crossref_primary_10_1002_iub_2105 crossref_primary_10_3389_fendo_2018_00715 crossref_primary_10_1002_lipd_12014 crossref_primary_10_3390_metabo15030201 crossref_primary_10_2147_JHC_S450423 crossref_primary_10_1002_mco2_339 crossref_primary_10_1146_annurev_physiol_021317_121550 crossref_primary_10_1016_j_gene_2020_144720 crossref_primary_10_1242_jcs_260943 crossref_primary_10_1016_j_prp_2020_152849 crossref_primary_10_3389_fonc_2023_1111094 crossref_primary_10_1124_jpet_119_262899 crossref_primary_10_1016_j_intimp_2024_111659 crossref_primary_10_1016_j_semcancer_2020_11_012 crossref_primary_10_1002_eji_201646903 crossref_primary_10_1097_MD_0000000000010203 crossref_primary_10_1177_1010428317699110 crossref_primary_10_3389_fphar_2016_00326 crossref_primary_10_3390_ijms241612762 crossref_primary_10_1016_j_jbo_2021_100378 crossref_primary_10_1016_j_meegid_2021_104883 crossref_primary_10_1038_s41375_020_01081_5 crossref_primary_10_1039_D2BM01271E crossref_primary_10_1016_j_jsbmb_2019_105377 crossref_primary_10_1038_s41598_023_35764_7 crossref_primary_10_1016_j_plipres_2018_06_001 crossref_primary_10_1007_s12672_025_02597_x crossref_primary_10_1155_2019_1805841 crossref_primary_10_3389_fphar_2018_01154 crossref_primary_10_32604_biocell_2023_028587 crossref_primary_10_3389_fcvm_2020_00065 crossref_primary_10_3389_fonc_2021_738177 crossref_primary_10_3892_ol_2018_7889 crossref_primary_10_1016_j_semcancer_2025_07_001 crossref_primary_10_3389_fphar_2016_00338 crossref_primary_10_1016_j_molmet_2022_101529 crossref_primary_10_3390_biomedicines12030514 crossref_primary_10_1016_j_apsb_2022_02_021 crossref_primary_10_1186_s12943_025_02258_1 crossref_primary_10_1093_jn_nxaa432 crossref_primary_10_1016_j_tem_2018_10_004 crossref_primary_10_1016_j_semcancer_2020_08_015 crossref_primary_10_1158_0008_5472_CAN_18_2529
Cites_doi	10.1074/jbc.M106445200 10.1016/j.coph.2012.07.009 10.1371/journal.pone.0096799 10.3109/10611860903156419 10.4049/jimmunol.181.10.7332 10.1074/jbc.M502777200 10.1186/bcr932 10.1016/j.atherosclerosis.2007.08.001 10.1016/j.numecd.2008.06.002 10.1158/1078-0432.CCR-05-1269 10.1002/ijc.26341 10.1186/1741-7015-12-54 10.1007/s10549-009-0594-8 10.1073/pnas.1213657110 10.1016/S1357-2725(02)00272-8 10.1038/89986 10.1593/neo.101372 10.1074/jbc.272.52.33068 10.1016/j.cca.2005.08.006 10.1074/jbc.272.28.17551 10.1186/bcr3483 10.1097/CAD.0b013e3282f1da86 10.1074/jbc.M109.020933 10.1038/nrc1910 10.1016/j.ajpath.2010.11.005 10.1111/eci.12185 10.1161/CIRCRESAHA.112.280081 10.1158/0008-5472.CAN-03-0675 10.1186/1479-5876-10-65 10.1016/j.breast.2004.11.005 10.1161/01.CIR.0000148368.79202.F1 10.1158/0008-5472.CAN-08-4051 10.1186/bcr3082 10.7150/thno.6617 10.1097/00041433-200110000-00004 10.1074/jbc.M211627200 10.1042/bj3490559 10.3322/caac.21254 10.1172/JCI14011 10.1371/journal.pone.0070390 10.1016/S0021-9258(17)46716-0 10.1002/pros.21072 10.1155/2011/496925
ContentType	Journal Article
Copyright	International Society of Oncology and BioMarkers (ISOBM) 2015 International Society of Oncology and BioMarkers (ISOBM) 2016
Copyright_xml	– notice: International Society of Oncology and BioMarkers (ISOBM) 2015 – notice: International Society of Oncology and BioMarkers (ISOBM) 2016
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO H94 K9. 7X8
DOI	10.1007/s13277-015-4141-4
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic
DatabaseTitleList	AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Chemistry
EISSN	1423-0380
EndPage	3588
ExternalDocumentID	4033751461 26456958 10_1007_s13277_015_4141_4
Genre	Journal Article Feature
GroupedDBID	--- .GJ 06D 0VX 0VY 0~B 123 1N0 203 29Q 29~ 2KM 2LR 2VQ 30V 30W 328 36B 3V. 4.4 408 40D 53G 67N 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8UI 8UJ 96X AAIAL AAJKR AARHV AARTL AASGM AAWCG AAYIC AAYIU AAYQN AAYTO AAYZH AAZMS ABBTS ABJOX ABPLI ABQXT ABTEG ABTHY ABTMW ABUWG ABWCG ACBXY ACGFS ACKNC ACPQW ACPRK ACQXL ADAGL ADBBV ADHIR ADINQ ADKPE ADZMO AEGNC AEJHL AENEX AEOHA AEPYU AETCA AEWDL AEYAO AFBBN AFCOW AFDXO AFKRA AFKRG AFLOW AFRWT AFSIO AFWTZ AFZKB AGAYW AGJBK AGQMX AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIIXL AIOMO AJBLW AJUZI AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP ANMIH AUTPY AYAKG AZQEC BBNVY BCNDV BDDNI BENPR BGNMA BHPHI BPHCQ BSEHC BVXVI CAG CCPQU COF CS3 CSCUP CYUIP DU5 DV7 DWQXO E0A EBD EBS EJD EMB EMOBN EN4 ESBYG F5P FB. FRRFC FYJPI FYUFA GGRSB GNUQQ GQ6 GQ7 GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GUQSH H13 HCIFZ HF~ HMCUK HMJXF HRMNR HZ~ IOS ITM J0Z J8X JBSCW K.F KOV LK8 M1P M2O M4Y M7P N9A NQS NU0 O1H O9- O93 O9I OK1 PADUT PIMPY PQQKQ PROAC PSQYO Q2X R9I RIG RKO ROL RSV RXVBD S1Z S27 S3A S3B SAUOL SBL SFC SHX SOJ SV3 T13 U2A U9L UDS UG4 UJ6 UKHRP VC2 W48 WK8 Z45 ZOVNA ZXP ~A9 0R~ AAYXX ABFSG ACHEB ACSTC AEZWR AFFHD AFHIU AHWEU AIXLP CITATION PHGZM PHGZT PJZUB PPXIY PQGLB SCNPE CGR CUY CVF ECM EIF NPM 7T5 7TO H94 K9. 7X8
ID	FETCH-LOGICAL-c372t-88fa86d9a80e984773876babde02ed0d61930b5c8b8768bfbe40f2a3d2ec8e3b3
IEDL.DBID	RSV
ISICitedReferencesCount	60
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000374903500084&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1010-4283
IngestDate	Thu Sep 04 19:58:20 EDT 2025 Fri Oct 03 11:11:25 EDT 2025 Thu Apr 03 07:05:22 EDT 2025 Tue Nov 18 22:23:37 EST 2025 Sat Nov 29 03:53:39 EST 2025 Fri Feb 21 02:38:32 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	3
Keywords	Immunohistochemistry Scavenger receptor class B type I Breast cancer Prognosis
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c372t-88fa86d9a80e984773876babde02ed0d61930b5c8b8768bfbe40f2a3d2ec8e3b3
Notes	SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23
PMID	26456958
PQID	1783934477
PQPubID	33651
PageCount	8
ParticipantIDs	proquest_miscellaneous_1784749237 proquest_journals_1783934477 pubmed_primary_26456958 crossref_primary_10_1007_s13277_015_4141_4 crossref_citationtrail_10_1007_s13277_015_4141_4 springer_journals_10_1007_s13277_015_4141_4
PublicationCentury	2000
PublicationDate	20160300 2016-3-00 2016-Mar 20160301
PublicationDateYYYYMMDD	2016-03-01
PublicationDate_xml	– month: 3 year: 2016 text: 20160300
PublicationDecade	2010
PublicationPlace	Dordrecht
PublicationPlace_xml	– name: Dordrecht – name: United States – name: London
PublicationSubtitle	Tumor Markers, Tumor Targeting and Translational Cancer Research
PublicationTitle	Tumor biology
PublicationTitleAbbrev	Tumor Biol
PublicationTitleAlternate	Tumour Biol
PublicationYear	2016
Publisher	Springer Netherlands Springer Nature B.V
Publisher_xml	– name: Springer Netherlands – name: Springer Nature B.V
References	Guo, Song, Li, Wu, Wang, Feng (CR11) 2009; 284 Nakamura, Yasuoka, Tsujimoto, Yoshidome, Nakahara, Nakao (CR34) 2006; 12 Mardones, Pilon, Bouly, Duran, Nishimoto, Arai (CR46) 2003; 278 Silver, Tall (CR27) 2001; 12 Yuhanna, Zhu, Cox, Hahner, Osborne-Lawrence, Lu (CR29) 2001; 7 Murao, Terpstra, Green, Kondratenko, Steinberg, Quehenberger (CR7) 1997; 272 Cao, Murao, Imachi, Yu, Abe, Yamauchi (CR9) 2004; 64 Loibl, Strank, von Minckwitz, Sinn, Buck, Solbach (CR31) 2005; 14 CR13 Krieger (CR10) 2001; 108 Han, Parsons, Zhou, Nicholson, Gotto, Hajjar (CR40) 2004; 110 Muntoni, Atzori, Mereu, Satta, Macis, Congia (CR5) 2009; 19 Remmele, Stegner (CR20) 1987; 8 Fukumura, Kashiwagi, Jain (CR32) 2006; 6 CR30 de Haan, van der Hoogt, Westerterp, Hoekstra, Dallinga-Thie, Princen (CR45) 2008; 197 Calvo, Vega (CR6) 1993; 268 Vilchez, Martinez-Ruiz, Sancho-Rodriguez, Martinez-Hernandez, Noguera-Velasco (CR14) 2014; 44 McConathy, Nair, Paranjape, Mooberry, Lacko (CR38) 2008; 19 Thompson, Sedlacek, Paul, Wolfe, McGinley, Playdon (CR4) 2012; 14 Cao, Garcia, Wyne, Schultz, Parker, Hobbs (CR8) 1997; 272 de Lorgeril, Salen (CR3) 2014; 12 Wadsack, Hirschmugl, Hammer, Levak-Frank, Kozarsky, Sattler (CR15) 2003; 35 Danilo, Gutierrez-Pajares, Mainieri, Mercier, Lisanti, Frank (CR19) 2013; 15 Leon, Locke, Adomat, Etinger, Twiddy, Neumann (CR16) 2010; 70 Pan, Ren, Lv, Zhao, Yu, He (CR24) 2012; 10 Bray, McCarron, Parkin (CR2) 2004; 6 Siegel, Miller, Jemal (CR1) 2015; 65 Yang, Damiano, Zhang, Tripathy, Luthi, Rink (CR37) 2013; 110 Shahzad, Mangala, Han, Lu, Bottsford-Miller, Nishimura (CR17) 2011; 13 Lahdenranta, Hagendoorn, Padera, Hoshida, Nelson, Kashiwagi (CR33) 2009; 69 Medina-Echeverz, Fioravanti, Diaz-Valdes, Frank, Aranda, Gomar (CR36) 2014; 9 Saddar, Carriere, Lee, Tanigaki, Yuhanna, Parathath (CR26) 2013; 112 Zhao, Wu, Hong, Ye, Wu (CR41) 2006; 365 Li, Kakinami, Li, Yang, Li (CR12) 2013; 8 Pussinen, Karten, Wintersperger, Reicher, McLean, Malle (CR23) 2000; 349 Lacko, Nair, Paranjape, Johnso, McConathy (CR35) 2002; 22 Mooberry, Nair, Paranjape, McConathy, Lacko (CR39) 2010; 18 Tsuruoka, Khovidhunkit, Brown, Fluhr, Elias, Feingold (CR42) 2002; 277 Lan, Silver (CR47) 2005; 280 CR44 Kimura, Mogi, Tomura, Kuwabara, Im, Sato (CR43) 2008; 181 Antalis, Arnold, Rasool, Lee, Buhman, Siddiqui (CR28) 2010; 122 Zheng, Liu, Jin, Pan, Qian, Huang (CR18) 2013; 3 Llaverias, Danilo, Mercier, Daumer, Capozza, Williams (CR21) 2011; 178 Danilo, Frank (CR22) 2012; 12 Pan, Ren, Ma, Liu, Yu, Ji (CR25) 2012; 131 WM Cao (4141_CR9) 2004; 64 D Calvo (4141_CR6) 1993; 268 Y Li (4141_CR12) 2013; 8 C Danilo (4141_CR22) 2012; 12 K Murao (4141_CR7) 1997; 272 PJ Pussinen (4141_CR23) 2000; 349 4141_CR13 W Haan de (4141_CR45) 2008; 197 S Saddar (4141_CR26) 2013; 112 IS Yuhanna (4141_CR29) 2001; 7 Y Nakamura (4141_CR34) 2006; 12 4141_CR30 J Lahdenranta (4141_CR33) 2009; 69 DL Silver (4141_CR27) 2001; 12 J Medina-Echeverz (4141_CR36) 2014; 9 LK Mooberry (4141_CR39) 2010; 18 C Danilo (4141_CR19) 2013; 15 H Tsuruoka (4141_CR42) 2002; 277 D Fukumura (4141_CR32) 2006; 6 F Bray (4141_CR2) 2004; 6 CJ Antalis (4141_CR28) 2010; 122 B Pan (4141_CR24) 2012; 10 C Wadsack (4141_CR15) 2003; 35 MMK Shahzad (4141_CR17) 2011; 13 P Mardones (4141_CR46) 2003; 278 G Llaverias (4141_CR21) 2011; 178 M Krieger (4141_CR10) 2001; 108 L Guo (4141_CR11) 2009; 284 HJ Thompson (4141_CR4) 2012; 14 Y Zheng (4141_CR18) 2013; 3 4141_CR44 CG Leon (4141_CR16) 2010; 70 WJ McConathy (4141_CR38) 2008; 19 S Loibl (4141_CR31) 2005; 14 RL Siegel (4141_CR1) 2015; 65 JA Vilchez (4141_CR14) 2014; 44 W Remmele (4141_CR20) 1987; 8 G Cao (4141_CR8) 1997; 272 B Pan (4141_CR25) 2012; 131 S Yang (4141_CR37) 2013; 110 D Lan (4141_CR47) 2005; 280 M Lorgeril de (4141_CR3) 2014; 12 J Han (4141_CR40) 2004; 110 SP Zhao (4141_CR41) 2006; 365 S Muntoni (4141_CR5) 2009; 19 AG Lacko (4141_CR35) 2002; 22 T Kimura (4141_CR43) 2008; 181 24111547 - Eur J Clin Invest. 2014 Jan;44(1):103-14 19318557 - Cancer Res. 2009 Apr 1;69(7):2801-8 24060386 - Breast Cancer Res. 2013;15(5):R87 21224077 - Am J Pathol. 2011 Jan;178(1):402-12 21805479 - Int J Cancer. 2012 Jul 1;131(1):70-82 15557368 - Circulation. 2004 Nov 30;110(22):3472-9 16620283 - Eur J Clin Invest. 2006 Apr;36(4):224-30 22462581 - J Transl Med. 2012 Mar 30;10:65 16489074 - Clin Cancer Res. 2006 Feb 15;12(4):1201-7 21472135 - Neoplasia. 2011 Apr;13(4):309-19 15535852 - Breast Cancer Res. 2004;6(6):229-39 9407090 - J Biol Chem. 1997 Dec 26;272(52):33068-76 19491399 - J Biol Chem. 2009 Jul 24;284(30):19826-34 11707442 - J Biol Chem. 2002 Jan 25;277(4):2916-22 18718745 - Nutr Metab Cardiovasc Dis. 2009 Mar;19(3):218-25 22867847 - Curr Opin Pharmacol. 2012 Dec;12(6):677-82 19851860 - Breast Cancer Res Treat. 2010 Aug;122(3):661-70 9211901 - J Biol Chem. 1997 Jul 11;272(28):17551-7 24669767 - BMC Med. 2014 Mar 27;12:54 14973113 - Cancer Res. 2004 Feb 15;64(4):1515-21 19866465 - Prostate. 2010 Mar 1;70(4):390-400 3303008 - Pathologe. 1987 May;8(3):138-40 18176115 - Anticancer Drugs. 2008 Feb;19(2):183-8 23894648 - PLoS One. 2013 Jul 24;8(7):e70390 23843895 - Theranostics. 2013 Jun 25;3(7):477-86 16185675 - Clin Chim Acta. 2006 Mar;365(1-2):119-24 10686538 - Tumour Biol. 2000 Mar-Apr;21(2):90-7 23345442 - Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2511-6 18981156 - J Immunol. 2008 Nov 15;181(10):7332-40 23023567 - Circ Res. 2013 Jan 4;112(1):140-51 7689561 - J Biol Chem. 1993 Sep 5;268(25):18929-35 17868678 - Atherosclerosis. 2008 Mar;197(1):57-63 15927832 - Breast. 2005 Jun;14(3):230-5 15837786 - J Biol Chem. 2005 Jun 17;280(24):23390-6 21490772 - Cholesterol. 2011;2011:496925 12511553 - J Biol Chem. 2003 Mar 7;278(10):7884-90 24797128 - PLoS One. 2014 May 05;9(5):e96799 11433352 - Nat Med. 2001 Jul;7(7):853-7 11560945 - J Clin Invest. 2001 Sep;108(6):793-7 16794635 - Nat Rev Cancer. 2006 Jul;6(7):521-34 25559415 - CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 11561168 - Curr Opin Lipidol. 2001 Oct;12(5):497-504 22225711 - Breast Cancer Res. 2012 Jan 06;14(1):R1 12174882 - Anticancer Res. 2002 Jul-Aug;22(4):2045-9 19637935 - J Drug Target. 2010 Jan;18(1):53-8 12565706 - Int J Biochem Cell Biol. 2003 Apr;35(4):441-54 10880355 - Biochem J. 2000 Jul 15;349(Pt 2):559-66
References_xml	– volume: 277 start-page: 2916 issue: 4 year: 2002 end-page: 2922 ident: CR42 article-title: Scavenger receptor class B type I is expressed in cultured keratinocytes and epidermis. Regulation in response to changes in cholesterol homeostasis and barrier requirements publication-title: J Biol Chem doi: 10.1074/jbc.M106445200 – volume: 12 start-page: 677 issue: 6 year: 2012 end-page: 682 ident: CR22 article-title: Cholesterol and breast cancer development publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2012.07.009 – volume: 9 issue: 5 year: 2014 ident: CR36 article-title: Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases publication-title: PLoS One doi: 10.1371/journal.pone.0096799 – volume: 18 start-page: 53 issue: 1 year: 2010 end-page: 58 ident: CR39 article-title: Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier publication-title: J Drug Target doi: 10.3109/10611860903156419 – volume: 181 start-page: 7332 issue: 10 year: 2008 end-page: 7340 ident: CR43 article-title: Induction of Scavenger Receptor Class B Type I Is Critical for Simvastatin Enhancement of High-Density Lipoprotein-Induced Anti-Inflammatory Actions in Endothelial Cells publication-title: J Immunol doi: 10.4049/jimmunol.181.10.7332 – volume: 280 start-page: 23390 issue: 24 year: 2005 end-page: 23396 ident: CR47 article-title: Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1 publication-title: J Biol Chem doi: 10.1074/jbc.M502777200 – volume: 6 start-page: 229 issue: 6 year: 2004 end-page: 239 ident: CR2 article-title: The changing global patterns of female breast cancer incidence and mortality publication-title: Breast Cancer Res doi: 10.1186/bcr932 – volume: 197 start-page: 57 issue: 1 year: 2008 end-page: 63 ident: CR45 article-title: Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.08.001 – volume: 19 start-page: 218 issue: 3 year: 2009 end-page: 225 ident: CR5 article-title: Serum lipoproteins and cancer publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2008.06.002 – volume: 12 start-page: 1201 issue: 4 year: 2006 end-page: 1207 ident: CR34 article-title: Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-1269 – ident: CR30 – volume: 70 start-page: 390 issue: 4 year: 2010 end-page: 400 ident: CR16 article-title: Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model publication-title: Prostate – volume: 131 start-page: 70 issue: 1 year: 2012 end-page: 82 ident: CR25 article-title: High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells publication-title: Int J Cancer doi: 10.1002/ijc.26341 – volume: 12 start-page: 54 year: 2014 ident: CR3 article-title: Helping women to good health: breast cancer, omega-3/omega-6 lipids, and related lifestyle factors publication-title: BMC Med doi: 10.1186/1741-7015-12-54 – volume: 122 start-page: 661 issue: 3 year: 2010 end-page: 670 ident: CR28 article-title: High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0594-8 – volume: 110 start-page: 2511 issue: 7 year: 2013 end-page: 2516 ident: CR37 article-title: Biomimetic, synthetic HDL nanostructures for lymphoma publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1213657110 – volume: 35 start-page: 441 issue: 4 year: 2003 end-page: 454 ident: CR15 article-title: Scavenger receptor class B, type I on non-malignant and malignant human epithelial cells mediates cholesteryl ester-uptake from high density lipoproteins publication-title: Int J Biochem Cell Biol doi: 10.1016/S1357-2725(02)00272-8 – volume: 7 start-page: 853 issue: 7 year: 2001 end-page: 857 ident: CR29 article-title: High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase publication-title: Nat Med doi: 10.1038/89986 – volume: 13 start-page: 309 issue: 4 year: 2011 end-page: IN308 ident: CR17 article-title: Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles publication-title: Neoplasia doi: 10.1593/neo.101372 – volume: 272 start-page: 33068 issue: 52 year: 1997 end-page: 33076 ident: CR8 article-title: Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1 publication-title: J Biol Chem doi: 10.1074/jbc.272.52.33068 – volume: 365 start-page: 119 issue: 1–2 year: 2006 end-page: 124 ident: CR41 article-title: Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits publication-title: Clin Chim Acta; Int J Clin Chem doi: 10.1016/j.cca.2005.08.006 – volume: 272 start-page: 17551 issue: 28 year: 1997 end-page: 17557 ident: CR7 article-title: Characterization of CLA-1, a Human Homologue of Rodent Scavenger Receptor BI, as a Receptor for High Density Lipoprotein and Apoptotic Thymocytes publication-title: J Biol Chem doi: 10.1074/jbc.272.28.17551 – volume: 15 start-page: R87 issue: 5 year: 2013 ident: CR19 article-title: Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development publication-title: Breast Cancer Res doi: 10.1186/bcr3483 – volume: 19 start-page: 183 issue: 2 year: 2008 end-page: 188 ident: CR38 article-title: Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e3282f1da86 – volume: 284 start-page: 19826 issue: 30 year: 2009 end-page: 19834 ident: CR11 article-title: Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response publication-title: J Biol Chem doi: 10.1074/jbc.M109.020933 – volume: 268 start-page: 18929 issue: 25 year: 1993 end-page: 18935 ident: CR6 article-title: Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family publication-title: J Biol Chem – volume: 6 start-page: 521 issue: 7 year: 2006 end-page: 534 ident: CR32 article-title: The role of nitric oxide in tumour progression publication-title: Nat Rev Cancer doi: 10.1038/nrc1910 – volume: 178 start-page: 402 issue: 1 year: 2011 end-page: 412 ident: CR21 article-title: Role of cholesterol in the development and progression of breast cancer publication-title: Am J Pathol doi: 10.1016/j.ajpath.2010.11.005 – ident: CR44 – volume: 44 start-page: 103 issue: 1 year: 2014 end-page: 114 ident: CR14 article-title: The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review publication-title: Eur J Clin Invest doi: 10.1111/eci.12185 – volume: 112 start-page: 140 issue: 1 year: 2013 end-page: 151 ident: CR26 article-title: Scavenger receptor class B type I is a plasma membrane cholesterol sensor publication-title: Circ Res doi: 10.1161/CIRCRESAHA.112.280081 – volume: 64 start-page: 1515 issue: 4 year: 2004 end-page: 1521 ident: CR9 article-title: A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-0675 – volume: 10 start-page: 65 year: 2012 ident: CR24 article-title: Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis publication-title: J Transl Med doi: 10.1186/1479-5876-10-65 – volume: 14 start-page: 230 issue: 3 year: 2005 end-page: 235 ident: CR31 article-title: Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer publication-title: Breast doi: 10.1016/j.breast.2004.11.005 – volume: 110 start-page: 3472 issue: 22 year: 2004 end-page: 3479 ident: CR40 article-title: Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104) publication-title: Circulation doi: 10.1161/01.CIR.0000148368.79202.F1 – volume: 69 start-page: 2801 issue: 7 year: 2009 end-page: 2808 ident: CR33 article-title: Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-4051 – volume: 14 start-page: R1 issue: 1 year: 2012 ident: CR4 article-title: Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors publication-title: Breast Cancer Res doi: 10.1186/bcr3082 – volume: 3 start-page: 477 issue: 7 year: 2013 end-page: 486 ident: CR18 article-title: Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles publication-title: Theranostics doi: 10.7150/thno.6617 – volume: 12 start-page: 497 issue: 5 year: 2001 end-page: 504 ident: CR27 article-title: The cellular biology of scavenger receptor class B type I publication-title: Curr Opin Lipidol doi: 10.1097/00041433-200110000-00004 – ident: CR13 – volume: 278 start-page: 7884 issue: 10 year: 2003 end-page: 7890 ident: CR46 article-title: Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice publication-title: J Biol Chem doi: 10.1074/jbc.M211627200 – volume: 22 start-page: 2045 issue: 4 year: 2002 end-page: 2049 ident: CR35 article-title: High density lipoprotein complexes as delivery vehicles for anticancer drugs publication-title: Anticancer Res – volume: 349 start-page: 559 issue: Pt 2 year: 2000 end-page: 566 ident: CR23 article-title: The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake publication-title: Biochem J doi: 10.1042/bj3490559 – volume: 65 start-page: 5 issue: 1 year: 2015 end-page: 29 ident: CR1 article-title: Cancer statistics, 2015 publication-title: CA Cancer J Clin doi: 10.3322/caac.21254 – volume: 8 start-page: 138 issue: 3 year: 1987 end-page: 140 ident: CR20 article-title: [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue] publication-title: Pathologe – volume: 108 start-page: 793 issue: 6 year: 2001 end-page: 797 ident: CR10 article-title: Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems publication-title: J Clin Investig doi: 10.1172/JCI14011 – volume: 8 issue: 7 year: 2013 ident: CR12 article-title: Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI publication-title: PLoS One doi: 10.1371/journal.pone.0070390 – volume: 181 start-page: 7332 issue: 10 year: 2008 ident: 4141_CR43 publication-title: J Immunol doi: 10.4049/jimmunol.181.10.7332 – volume: 108 start-page: 793 issue: 6 year: 2001 ident: 4141_CR10 publication-title: J Clin Investig doi: 10.1172/JCI14011 – volume: 12 start-page: 1201 issue: 4 year: 2006 ident: 4141_CR34 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-1269 – volume: 19 start-page: 183 issue: 2 year: 2008 ident: 4141_CR38 publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e3282f1da86 – volume: 268 start-page: 18929 issue: 25 year: 1993 ident: 4141_CR6 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)46716-0 – volume: 178 start-page: 402 issue: 1 year: 2011 ident: 4141_CR21 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2010.11.005 – volume: 70 start-page: 390 issue: 4 year: 2010 ident: 4141_CR16 publication-title: Prostate doi: 10.1002/pros.21072 – volume: 12 start-page: 497 issue: 5 year: 2001 ident: 4141_CR27 publication-title: Curr Opin Lipidol doi: 10.1097/00041433-200110000-00004 – volume: 6 start-page: 521 issue: 7 year: 2006 ident: 4141_CR32 publication-title: Nat Rev Cancer doi: 10.1038/nrc1910 – volume: 197 start-page: 57 issue: 1 year: 2008 ident: 4141_CR45 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.08.001 – volume: 112 start-page: 140 issue: 1 year: 2013 ident: 4141_CR26 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.112.280081 – ident: 4141_CR13 doi: 10.1155/2011/496925 – volume: 110 start-page: 3472 issue: 22 year: 2004 ident: 4141_CR40 publication-title: Circulation doi: 10.1161/01.CIR.0000148368.79202.F1 – volume: 6 start-page: 229 issue: 6 year: 2004 ident: 4141_CR2 publication-title: Breast Cancer Res doi: 10.1186/bcr932 – volume: 122 start-page: 661 issue: 3 year: 2010 ident: 4141_CR28 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0594-8 – volume: 8 issue: 7 year: 2013 ident: 4141_CR12 publication-title: PLoS One – volume: 3 start-page: 477 issue: 7 year: 2013 ident: 4141_CR18 publication-title: Theranostics doi: 10.7150/thno.6617 – volume: 131 start-page: 70 issue: 1 year: 2012 ident: 4141_CR25 publication-title: Int J Cancer doi: 10.1002/ijc.26341 – volume: 12 start-page: 677 issue: 6 year: 2012 ident: 4141_CR22 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2012.07.009 – volume: 9 issue: 5 year: 2014 ident: 4141_CR36 publication-title: PLoS One doi: 10.1371/journal.pone.0096799 – volume: 110 start-page: 2511 issue: 7 year: 2013 ident: 4141_CR37 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1213657110 – volume: 272 start-page: 33068 issue: 52 year: 1997 ident: 4141_CR8 publication-title: J Biol Chem doi: 10.1074/jbc.272.52.33068 – volume: 8 start-page: 138 issue: 3 year: 1987 ident: 4141_CR20 publication-title: Pathologe – volume: 12 start-page: 54 year: 2014 ident: 4141_CR3 publication-title: BMC Med doi: 10.1186/1741-7015-12-54 – volume: 18 start-page: 53 issue: 1 year: 2010 ident: 4141_CR39 publication-title: J Drug Target doi: 10.3109/10611860903156419 – volume: 69 start-page: 2801 issue: 7 year: 2009 ident: 4141_CR33 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-4051 – volume: 19 start-page: 218 issue: 3 year: 2009 ident: 4141_CR5 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2008.06.002 – volume: 15 start-page: R87 issue: 5 year: 2013 ident: 4141_CR19 publication-title: Breast Cancer Res doi: 10.1186/bcr3483 – volume: 278 start-page: 7884 issue: 10 year: 2003 ident: 4141_CR46 publication-title: J Biol Chem doi: 10.1074/jbc.M211627200 – ident: 4141_CR30 – volume: 13 start-page: 309 issue: 4 year: 2011 ident: 4141_CR17 publication-title: Neoplasia doi: 10.1593/neo.101372 – volume: 44 start-page: 103 issue: 1 year: 2014 ident: 4141_CR14 publication-title: Eur J Clin Invest doi: 10.1111/eci.12185 – volume: 272 start-page: 17551 issue: 28 year: 1997 ident: 4141_CR7 publication-title: J Biol Chem doi: 10.1074/jbc.272.28.17551 – volume: 22 start-page: 2045 issue: 4 year: 2002 ident: 4141_CR35 publication-title: Anticancer Res – volume: 65 start-page: 5 issue: 1 year: 2015 ident: 4141_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21254 – volume: 7 start-page: 853 issue: 7 year: 2001 ident: 4141_CR29 publication-title: Nat Med doi: 10.1038/89986 – volume: 14 start-page: 230 issue: 3 year: 2005 ident: 4141_CR31 publication-title: Breast doi: 10.1016/j.breast.2004.11.005 – volume: 280 start-page: 23390 issue: 24 year: 2005 ident: 4141_CR47 publication-title: J Biol Chem doi: 10.1074/jbc.M502777200 – volume: 277 start-page: 2916 issue: 4 year: 2002 ident: 4141_CR42 publication-title: J Biol Chem doi: 10.1074/jbc.M106445200 – ident: 4141_CR44 – volume: 284 start-page: 19826 issue: 30 year: 2009 ident: 4141_CR11 publication-title: J Biol Chem doi: 10.1074/jbc.M109.020933 – volume: 64 start-page: 1515 issue: 4 year: 2004 ident: 4141_CR9 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-0675 – volume: 35 start-page: 441 issue: 4 year: 2003 ident: 4141_CR15 publication-title: Int J Biochem Cell Biol doi: 10.1016/S1357-2725(02)00272-8 – volume: 349 start-page: 559 issue: Pt 2 year: 2000 ident: 4141_CR23 publication-title: Biochem J doi: 10.1042/bj3490559 – volume: 365 start-page: 119 issue: 1–2 year: 2006 ident: 4141_CR41 publication-title: Clin Chim Acta; Int J Clin Chem doi: 10.1016/j.cca.2005.08.006 – volume: 14 start-page: R1 issue: 1 year: 2012 ident: 4141_CR4 publication-title: Breast Cancer Res doi: 10.1186/bcr3082 – volume: 10 start-page: 65 year: 2012 ident: 4141_CR24 publication-title: J Transl Med doi: 10.1186/1479-5876-10-65 – reference: 22462581 - J Transl Med. 2012 Mar 30;10:65 – reference: 21490772 - Cholesterol. 2011;2011:496925 – reference: 14973113 - Cancer Res. 2004 Feb 15;64(4):1515-21 – reference: 15837786 - J Biol Chem. 2005 Jun 17;280(24):23390-6 – reference: 24060386 - Breast Cancer Res. 2013;15(5):R87 – reference: 25559415 - CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 – reference: 24797128 - PLoS One. 2014 May 05;9(5):e96799 – reference: 10686538 - Tumour Biol. 2000 Mar-Apr;21(2):90-7 – reference: 16185675 - Clin Chim Acta. 2006 Mar;365(1-2):119-24 – reference: 12511553 - J Biol Chem. 2003 Mar 7;278(10):7884-90 – reference: 24111547 - Eur J Clin Invest. 2014 Jan;44(1):103-14 – reference: 22867847 - Curr Opin Pharmacol. 2012 Dec;12(6):677-82 – reference: 15535852 - Breast Cancer Res. 2004;6(6):229-39 – reference: 11561168 - Curr Opin Lipidol. 2001 Oct;12(5):497-504 – reference: 23894648 - PLoS One. 2013 Jul 24;8(7):e70390 – reference: 7689561 - J Biol Chem. 1993 Sep 5;268(25):18929-35 – reference: 18176115 - Anticancer Drugs. 2008 Feb;19(2):183-8 – reference: 21805479 - Int J Cancer. 2012 Jul 1;131(1):70-82 – reference: 23345442 - Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2511-6 – reference: 23023567 - Circ Res. 2013 Jan 4;112(1):140-51 – reference: 18981156 - J Immunol. 2008 Nov 15;181(10):7332-40 – reference: 21224077 - Am J Pathol. 2011 Jan;178(1):402-12 – reference: 18718745 - Nutr Metab Cardiovasc Dis. 2009 Mar;19(3):218-25 – reference: 10880355 - Biochem J. 2000 Jul 15;349(Pt 2):559-66 – reference: 19866465 - Prostate. 2010 Mar 1;70(4):390-400 – reference: 16794635 - Nat Rev Cancer. 2006 Jul;6(7):521-34 – reference: 9211901 - J Biol Chem. 1997 Jul 11;272(28):17551-7 – reference: 15557368 - Circulation. 2004 Nov 30;110(22):3472-9 – reference: 22225711 - Breast Cancer Res. 2012 Jan 06;14(1):R1 – reference: 23843895 - Theranostics. 2013 Jun 25;3(7):477-86 – reference: 17868678 - Atherosclerosis. 2008 Mar;197(1):57-63 – reference: 19491399 - J Biol Chem. 2009 Jul 24;284(30):19826-34 – reference: 11433352 - Nat Med. 2001 Jul;7(7):853-7 – reference: 12174882 - Anticancer Res. 2002 Jul-Aug;22(4):2045-9 – reference: 12565706 - Int J Biochem Cell Biol. 2003 Apr;35(4):441-54 – reference: 19637935 - J Drug Target. 2010 Jan;18(1):53-8 – reference: 19851860 - Breast Cancer Res Treat. 2010 Aug;122(3):661-70 – reference: 3303008 - Pathologe. 1987 May;8(3):138-40 – reference: 11707442 - J Biol Chem. 2002 Jan 25;277(4):2916-22 – reference: 11560945 - J Clin Invest. 2001 Sep;108(6):793-7 – reference: 19318557 - Cancer Res. 2009 Apr 1;69(7):2801-8 – reference: 24669767 - BMC Med. 2014 Mar 27;12:54 – reference: 9407090 - J Biol Chem. 1997 Dec 26;272(52):33068-76 – reference: 21472135 - Neoplasia. 2011 Apr;13(4):309-19 – reference: 15927832 - Breast. 2005 Jun;14(3):230-5 – reference: 16489074 - Clin Cancer Res. 2006 Feb 15;12(4):1201-7 – reference: 16620283 - Eur J Clin Invest. 2006 Apr;36(4):224-30
SSID	ssj0015996
Score	2.3466625
Snippet	Scavenger receptor class B type I (SR-BI) has been linked to the development and progression of breast cancer. However, its clinical significance in breast...
SourceID	proquest pubmed crossref springer
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	3581
SubjectTerms	Adult Aged Biomarkers, Tumor - biosynthesis Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer Research Female Follow-Up Studies Humans Immunohistochemistry Kaplan-Meier Estimate Lymphatic Metastasis Medical prognosis Middle Aged Multivariate Analysis Neoplasm Staging Original Article Prognosis Proportional Hazards Models Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Scavenger Receptors, Class B - biosynthesis Tissue Array Analysis - methods Tissue Array Analysis - statistics & numerical data Tumor Burden Tumors
Title	High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer
URI	https://link.springer.com/article/10.1007/s13277-015-4141-4 https://www.ncbi.nlm.nih.gov/pubmed/26456958 https://www.proquest.com/docview/1783934477 https://www.proquest.com/docview/1784749237
Volume	37
WOSCitedRecordID	wos000374903500084&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1423-0380 dateEnd: 20161231 omitProxy: false ssIdentifier: ssj0015996 issn: 1010-4283 databaseCode: RSV dateStart: 20100101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9QwzGIDAS8wxoAb22QknkCVetfcJXlkExM8ME0bTPdWNYmDTmLt6dpD-_nYvfY2NIYEr6njRLHjj9qxAd6qYCypoBJWPTZR0djEOr7uNIws_IaGMvJtswl9cmKmU3vaveOu-2z3PiTZSurrx26ZhBtZfSVqqNjx2YD7rO2M9Gs4O79Yhw6k3kgb4uQVpZpYH8r8E4rfldEtC_NWdLRVOsdP_2u7W_CkszHxw4opnsE9Krfh0VHf2m0bHn7pIurP4UoSPbD20lWekSMLQJqzH45ezGo8RPlHi5-RrrqM2RJnNbYvYChgU2GzvGTo4nvrt3eiE4sy4LzicUn_Kquap8xKdJIA36AXRlvswLfjj1-PPiVdN4bEZ3rUJMbEwkyCLUxKlnWazliQusIFSkcU0sCeWJa6sTeOx42LjlQaR0UWRuSZ5C57AZtlVdIrQMYRKfPex6jZoSQbWG4UVsWgyafaDiDtyZL7rlS5dMz4kV8XWZbTzfl0czndXA3g3XrKfFWn42_Aez2t8-7K1vlQs60o9Q_1AN6sPzNhJIJSlFQtWxilpaQdw7xc8ch6NbYsxxM7NgN43zPEDeR3bWX3n6Bfw2M22CarHLg92GwWS9qHB_5nM6sXB7Chp-agvQ2_APSDAxw
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9QwzIKBGC8DxoDbBhiJJ1Cl3jV3SR5h2rSJ7YRgoL1VTeKgk6A9XXtoPx-7195AAyR4TR0nih1_1I4N8FIFY0kFlbDqsYmKxibW8XWnYWThNzSUkW-bTejp1Fxc2PfdO-66z3bvQ5KtpL567JZJuJHVV6KGih2fm3BLscKSgvkfPn5ehw6k3kgb4uQVpZpYH8r8HYpfldE1C_NadLRVOkf3_mu792GrszHxzYopHsANKrdh86Bv7bYNd866iPpDuJRED6y9dJVn5MgCkObsh6MXsxrfovyjxROkyy5jtsRZje0LGArYVNgsvzF08aX12zvRiUUZcF7xuKR_lVXNU2YlOkmAb9ALoy124NPR4fnBcdJ1Y0h8pkdNYkwszCTYwqRkWafpjAWpK1ygdEQhDeyJZakbe-N43LjoSKVxVGRhRJ5J7rJHsFFWJT0BZByRMu99jJodSrKB5UZhVQyafKrtANKeLLnvSpVLx4yv-VWRZTndnE83l9PN1QBerafMV3U6_ga839M6765snQ8124pS_1AP4MX6MxNGIihFSdWyhVFaStoxzOMVj6xXY8tyPLFjM4DXPUP8hPxPW9n9J-jnsHl8fnaan55M3-3BXTbeJqt8uH3YaBZLegq3_fdmVi-etXfiBwZeBRg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZbxMxEB6VFpW-cJQrpYCReAKtusk6sf0IpREVEFXiUN9Wa3uMIoE3ym6q_vzO7JGCCkior97xIXs8x874G4CX0muD0suEVI9JZNAmMZauOw4DCb-hxgxdU2xCzWb69NScdHVOqz7bvQ9Jtm8aGKUp1gcLHw4uH75lHHokVZbIoSQn6AZsSc6jZ3f987d1GIGxR5pwJ83OyGJ9WPNPQ_yumK5Ym1cipY0Cmt659tLvwu3O9hRvWma5BxsYd-HWYV_ybRe2P3WR9vtwzgkgonJcbZ4mEiQYcUH-uXBsbou3gv_dimOB510mbRTzSjQvY9CLuhT16idRF98bf74TqaKIXixKaue0sFhW1GUeheXE-Fo4ZsDlA_g6Pfpy-D7pqjQkLlOjOtE6FHriTaFTNKTrVEYC1hbWYzpCn3ry0LLUjp221K5tsCjTMCoyP0JHrGCzh7AZy4iPQdAYATPnXAiKHE00nuRJYWTwCl2qzADS_ohy10GYcyWNH_kl-DLvbk67m_Pu5nIAr9ZdFi1-x7-I9_tzz7urXOVDRTYk4yKqAbxYf6aD4chKEbFcNTRSMdQd0Txq-WU9G1mc44kZ6wG87pnjl8H_tpS9_6J-Dtsn76b5x-PZhyewQzbdpE2T24fNernCp3DTndXzavmsuR4XJT4N_A
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+scavenger+receptor+class+B+type+I+expression+is+related+to+tumor+aggressiveness+and+poor+prognosis+in+breast+cancer&rft.jtitle=Tumor+biology&rft.au=Yuan%2C+Baoying&rft.au=Wu%2C+Changshun&rft.au=Wang%2C+Xingwen&rft.au=Wang%2C+Dan&rft.date=2016-03-01&rft.pub=Springer+Nature+B.V&rft.issn=1010-4283&rft.eissn=1423-0380&rft.volume=37&rft.issue=3&rft.spage=3581&rft_id=info:doi/10.1007%2Fs13277-015-4141-4&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=4033751461
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1010-4283&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1010-4283&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1010-4283&client=summon